Literature DB >> 3094633

Pancreatitis induced by oestrogen in a patient with type I hyperlipoproteinaemia.

P M Stuyt, P N Demacker, A F Stalenhoef.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3094633      PMCID： PMC1341453          DOI： 10.1136/bmj.293.6549.734

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy.

Authors:  F Davidoff; S Tishler; C Rosoff
Journal:  N Engl J Med       Date:  1973-09-13       Impact factor: 91.245

2.  Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia.

Authors:  C J Glueck; D Scheel; J Fishback; P Steiner
Journal:  Metabolism       Date:  1972-07       Impact factor: 8.694

3.  Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.

Authors:  A F Stalenhoef; A F Casparie; P N Demacker; J T Stouten; J A Lutterman; A van 't Laar
Journal:  Metabolism       Date:  1981-09       Impact factor: 8.694
  3 in total
  3 in total

Review 1.  Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Anton Stalenhoef
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-10-17       Impact factor: 4.690

Review 2.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

Review 3.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.